UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4

The international journal of biochemistry & cell biology, 2013-09, Vol.45 (9), p.1962-1973

2013

Volltextzugriff (PDF)

SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/[beta]-catenin signaling

Cancer letters, 2016-05, Vol.375 (1), p.100

2016

Volltextzugriff (PDF)

CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population

DNA and cell biology, 2012-06, Vol.31 (6), p.1107

2012

Volltextzugriff (PDF)

Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis

Cancer gene therapy, 2021-04, Vol.28 (3-4), p.279-293

2021

Volltextzugriff (PDF)

Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma

Cancer science, 2019-03, Vol.110 (3), p.950-961

2019

Volltextzugriff (PDF)

C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis

PloS one, 2013-11, Vol.8 (11), p.e79137-e79137

2013

Volltextzugriff (PDF)

Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification

Nature communications, 2022-02, Vol.13 (1), p.617-617, Article 617

2022

Volltextzugriff (PDF)

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)

Journal of hematology and oncology, 2019-02, Vol.12 (1), p.16-11, Article 16

2019

Volltextzugriff (PDF)

Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000437

2020

Volltextzugriff (PDF)

Increased methylation of ZNF671 suppresses tumor progression by promoting MAPK6 transcription in laryngeal carcinoma

International journal of biological sciences, 2023, Vol.19 (8), p.2443-2457

2023

Volltextzugriff (PDF)

Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients

Clinical chemistry and laboratory medicine, 2019-09, Vol.57 (10), p.1501

2019

Volltextzugriff (PDF)

The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH -MYCN transgenic neuroblastoma mouse model

Cancer letters, 2017-08, Vol.400, p.61-68

2017

Volltextzugriff (PDF)

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Liver cancer (Basel ), 2023-10, Vol.12 (5), p.405-444

2023

Volltextzugriff (PDF)

ER-phagy in the Occurrence and Development of Cancer

Biomedicines, 2022-03, Vol.10 (3), p.707

2022

Volltextzugriff (PDF)

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Liver cancer (Basel ), 2020-12, Vol.9 (6), p.682-720

2020

Volltextzugriff (PDF)

11C-methionine PET imaging characteristics in children with diffuse intrinsic pontine gliomas and relationship to survival and H3 K27M mutation status

European journal of nuclear medicine and molecular imaging, 2023-05, Vol.50 (6), p.1709-1719

2023

Volltextzugriff (PDF)

Identifying HER2 from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab‐based therapy

Cancer medicine (Malden, MA), 2023-02, Vol.12 (4), p.4110-4124

2023

Volltextzugriff (PDF)

KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9

Oncogene, 2011-04, Vol.30 (16), p.1901-1911

2011

Volltextzugriff (PDF)

First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial

Journal for immunotherapy of cancer, 2024-02, Vol.12 (2), p.e007227

2024

Volltextzugriff (PDF)

Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies

Nature communications, 2022-09, Vol.13 (1), Article 5723

2022

Volltextzugriff (PDF)

Analysis of UGT1A128 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai

Journal of cancer research and clinical oncology, 2013-09, Vol.139 (9), p.1579-1589

2013

Volltextzugriff (PDF)

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer

BMC cancer, 2017-03, Vol.17 (1), p.188-188, Article 188

2017

Volltextzugriff (PDF)

Consideration of the Role of Radiotherapy for Abdominal Lymph Node Metastases in Patients With Recurrent Gastric Cancer

International journal of radiation oncology, biology, physics, 2010-06, Vol.77 (2), p.384-391

2010

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaPhysical Sciences

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4

SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/[beta]-catenin signaling

CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population

Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis

Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma

C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification

Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Increased methylation of ZNF671 suppresses tumor progression by promoting MAPK6 transcription in laryngeal carcinoma

Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients

The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH -MYCN transgenic neuroblastoma mouse model

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

ER-phagy in the Occurrence and Development of Cancer

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

11C-methionine PET imaging characteristics in children with diffuse intrinsic pontine gliomas and relationship to survival and H3 K27M mutation status

Identifying HER2 from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab‐based therapy

KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9

First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial

Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies

Analysis of UGT1A128 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer

Consideration of the Role of Radiotherapy for Abdominal Lymph Node Metastases in Patients With Recurrent Gastric Cancer

Aktive Filter

Suchergebnisse filtern